Pure Global

BD BBL Sensi-Disc Piperacillin/Tazobactam -100/10 µg - HSA Registration DE0508530

Access comprehensive regulatory information for BD BBL Sensi-Disc Piperacillin/Tazobactam -100/10 µg in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0508530 and owned by Becton, Dickinson & Company. The device was registered on September 29, 2023.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS B IVD
DE0508530
BD BBL Sensi-Disc Piperacillin/Tazobactam -100/10 µg
HSA Registration Number: DE0508530
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

These discs are used for semi-quantitative in vitro susceptibility testing by the agar disc diffusion test procedure of common, rapidly growing and certain fastidious bacterial pathogens.

Device Classification
Device Class
CLASS B IVD
Medical Speciality Area
Clinical chemistry
Registration Information
Registration Number
DE0508530
Registration Date
September 29, 2023
Retention Due Date
September 28, 2025
Product Owner
Short Name
Becton, Dickinson & Company
Address
Becton, Dickinson and Company, BD Biosciences, 155 North McCarthy Boulevard, Milpitas, California 95035, UNITED STATES
Registrant
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Importer
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Model Information
Model Name(s)
BD BBL Sensi-Disc Piperacillin/Tazobactam -100/10 µg
Model Identifier(s)
231691